{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:14:54Z","timestamp":1783577694751,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015539","name":"Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015539","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2016801"],"award-info":[{"award-number":["APP2016801"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.vaccine.2024.01.040","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T16:56:53Z","timestamp":1706029013000},"page":"1034-1041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The association between influenza vaccination, cardiovascular mortality and hospitalization: A living systematic review and prospective meta-analysis"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8609-5463","authenticated-orcid":false,"given":"Rong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7580-2230","authenticated-orcid":false,"given":"Yihang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3825-4092","authenticated-orcid":false,"given":"Anushka","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9077-8673","authenticated-orcid":false,"given":"Hueiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7463-8707","authenticated-orcid":false,"given":"Xin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0787-5825","authenticated-orcid":false,"given":"Bette","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5470-3567","authenticated-orcid":false,"given":"Gian Luca","family":"Di Tanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.vaccine.2024.01.040_b0005","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation"},{"issue":"29","key":"10.1016\/j.vaccine.2024.01.040_b0010","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"issue":"36","key":"10.1016\/j.vaccine.2024.01.040_b0015","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.vaccine.2024.01.040_b0020","doi-asserted-by":"crossref","first-page":"e019671","DOI":"10.1161\/JAHA.120.019671","article-title":"Determinants of influenza vaccine uptake in patients with cardiovascular disease and strategies for improvement","volume":"10","author":"Bhugra","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.vaccine.2024.01.040_b0025","doi-asserted-by":"crossref","first-page":"e0001947","DOI":"10.1371\/journal.pgph.0001947","article-title":"Cluster randomized trial of influenza vaccination in patients with acute heart failure in China: A mixed-methods feasibility study","volume":"3","author":"Liu","year":"2023","journal-title":"PLOS Glob Public Health"},{"issue":"2","key":"10.1016\/j.vaccine.2024.01.040_b0030","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jchf.2015.10.012","article-title":"Influenza vaccination in patients with chronic heart failure: the PARADIGM-HF trial","volume":"4","author":"Vardeny","year":"2016","journal-title":"JACC Heart failure"},{"issue":"47","key":"10.1016\/j.vaccine.2024.01.040_b0035","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1016\/j.vaccine.2016.10.013","article-title":"Seasonal influenza vaccination in China: Landscape of diverse regional reimbursement policy, and budget impact analysis","volume":"34","author":"Yang","year":"2016","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2024.01.040_b0040","doi-asserted-by":"crossref","first-page":"e042487","DOI":"10.1136\/bmjopen-2020-042487","article-title":"Influenza-associated cardiovascular mortality in older adults in Beijing, China: a population-based time-series study","volume":"10","author":"Liu","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2024.01.040_b0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jclinepi.2017.08.010","article-title":"Living systematic review: 1. Introduction-the why, what, when, and how","volume":"91","author":"Elliott","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2024.01.040_b0050","article-title":"A guide to prospective meta-analysis","volume":"367","author":"Seidler","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2024.01.040_b0055","unstructured":"Du X. A cluster randomized pilot trial evaluating the feasibility of intervening heart failure patients with influenza vaccines. Chinese Clinical Trial Registry; November 30, 2021. ChiCTR2000039081. http:\/\/www.chictr.org.cn\/showprojen.aspx?proj=62869 [accessed October 22, 2022]."},{"key":"10.1016\/j.vaccine.2024.01.040_b0060","unstructured":"Du X. Influenza vaccination on preventing all-cause mortality or all-cause readmission in patients with hospitalized heart failure: a cluster randomized trial; September 19, 2022. ChiCTR2100053264 http:\/\/www.chictr.org.cn\/showprojen.aspx?proj=135167 [accessed October 22, 2022]."},{"issue":"1","key":"10.1016\/j.vaccine.2024.01.040_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"System Rev"},{"key":"10.1016\/j.vaccine.2024.01.040_b0070","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"Shamseer","year":"2015","journal-title":"BMJ: Brit Med J"},{"key":"10.1016\/j.vaccine.2024.01.040_b0075","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2024.01.040_b0080","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.vaccine.2024.01.040_b0085","doi-asserted-by":"crossref","first-page":"e054171","DOI":"10.1136\/bmjopen-2021-054171","article-title":"Association between influenza vaccination, all-cause mortality and cardiovascular mortality: a protocol for a living systematic review and prospective meta-analysis","volume":"12","author":"Liu","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2024.01.040_b0090","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.vaccine.2024.01.040_b0095","unstructured":"Version 2 of the Cochrane risk-of-bias tool for randomized trials (RoB 2) https:\/\/methods.cochrane.org\/bias\/resources\/rob-2-revised-cochrane-risk-bias-tool-randomized-trials."},{"key":"10.1016\/j.vaccine.2024.01.040_b0100","unstructured":"Risk Of Bias In Non-Randomized Studies - of Interventions. https:\/\/methods.cochrane.org\/bias\/risk-bias-non-randomized-studies-interventions."},{"issue":"4","key":"10.1016\/j.vaccine.2024.01.040_b0105","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2024.01.040_b0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2288-8-79","article-title":"Undue reliance on I(2) in assessing heterogeneity may mislead","volume":"8","author":"R\u00fccker","year":"2008","journal-title":"BMC Med Res Methodol"},{"issue":"7","key":"10.1016\/j.vaccine.2024.01.040_b0115","doi-asserted-by":"crossref","first-page":"e010247","DOI":"10.1136\/bmjopen-2015-010247","article-title":"Plea for routinely presenting prediction intervals in meta-analysis","volume":"6","author":"IntHout","year":"2016","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.vaccine.2024.01.040_b0120","doi-asserted-by":"crossref","first-page":"e1835","DOI":"10.1016\/S2214-109X(22)00432-6","article-title":"Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial","volume":"10","author":"Loeb","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2024.01.040_b0125","doi-asserted-by":"crossref","unstructured":"Adams K, Riddles JJ, Rowley EAK, et al. Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021-February 2022, VISION Network: a retrospective cohort study. The Lancet Regional Health \u2013 Americas. 2023;23. doi: 10.1016\/j.lana.2023.100530.","DOI":"10.1016\/j.lana.2023.100530"},{"issue":"1","key":"10.1016\/j.vaccine.2024.01.040_b0130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.01.040_b0135","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.2945","article-title":"Influenza vaccination and cardiovascular events in patients with ischaemic heart disease and heart failure: A meta-analysis","author":"Modin","year":"2023","journal-title":"European J Heart Failure"},{"key":"10.1016\/j.vaccine.2024.01.040_b0140","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.121.057042","article-title":"Influenza Vaccination after Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled","author":"Fr\u00f8bert","year":"2021","journal-title":"Multicenter Trial Circulation"},{"issue":"14","key":"10.1016\/j.vaccine.2024.01.040_b0145","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/eurheartj\/ehr004","article-title":"Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome","volume":"32","author":"Phrommintikul","year":"2011","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.vaccine.2024.01.040_b0150","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.vaccine.2009.09.092","article-title":"Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older","volume":"28","author":"De Villiers","year":"2009","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2024.01.040_b0155","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/eurheartj\/ehm581","article-title":"Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study","volume":"29","author":"Ciszewski","year":"2008","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.vaccine.2024.01.040_b0160","first-page":"639","article-title":"Is influenza vaccination cost effective for healthy people between ages 65 and 74 years? A randomised controlled trial","volume":"23","author":"Allsup","year":"2004","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24000537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24000537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:34:26Z","timestamp":1759404866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24000537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0264410X24000537"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.01.040","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between influenza vaccination, cardiovascular mortality and hospitalization: A living systematic review and prospective meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.01.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}